The Goldman Sachs Group Upgrades Sonic Healthcare (OTCMKTS:SKHHY) to Strong-Buy

Posted by ABMN Staff on Apr 7th, 2025

The Goldman Sachs Group upgraded shares of Sonic Healthcare (OTCMKTS:SKHHY – Free Report) to a strong-buy rating in a report issued on Friday,Zacks.com reports.

Separately, Morgan Stanley set a $28.10 price target on Sonic Healthcare in a research note on Wednesday, March 19th.

Check Out Our Latest Research Report on Sonic Healthcare

Sonic Healthcare Price Performance

Shares of SKHHY opened at $15.62 on Friday. The company’s fifty day moving average price is $17.15 and its 200-day moving average price is $17.57. Sonic Healthcare has a 1-year low of $15.24 and a 1-year high of $20.59.

Sonic Healthcare Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Monday, March 31st. Shareholders of record on Thursday, March 6th were paid a dividend of $0.2816 per share. The ex-dividend date of this dividend was Thursday, March 6th.

Sonic Healthcare Company Profile

(Get Free Report)

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry.